Highlights from ACR Convergence 2023
RA
RheumNow
ACR Convergence 2023 Highlights: Assessment and Treatment of Cardiovascular Risks in Rheumatoid Arthritis
FEATURING
Antoni Chan
- 1 view
- November 22, 2023
RheumNow
ACR Convergence 2023 Highlights: Can We Prevent RA? Results from the APIPPRA Trial
FEATURING
Jonathan Kay,
Andrew Cope
- 145 views
- November 22, 2023
RheumNow
ACR Convergence 2023 Highlights: No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
FEATURING
Michael Putman,
Madeline O'Sullivan
- 4 views
- November 22, 2023
RheumNow
ACR Convergence 2023 Highlights: The SMART Study: Split Dose Oral Methotrexate
FEATURING
John J. Cush
- 9 views
- November 22, 2023
RheumNow
ACR Convergence 2023 Highlights: Simulated JAK Trials to Counter ORAL Surveillance
FEATURING
John J. Cush,
Janet Pope
- 166 views
- November 22, 2023
RheumNow
ACR Convergence 2023 Highlights: EXXELERATE Study: Do High RF Titers Impact Response to TNF Inhibitors?
FEATURING
Jonathan Kay,
Josef Smolen
- 18 views
- November 24, 2023
RheumNow
ACR Convergence 2023 Highlights: Steroids and MACE in RA
FEATURING
Aurelie Najm
- 6 views
- November 28, 2023
RheumNow
ACR Convergence 2023 Highlights: Older RA Patients Just Aren't Getting Treated
FEATURING
David Liew,
Jiha Lee
- 4 views
- November 28, 2023
RheumNow
ACR Convergence 2023 Highlights: Does Diet Matter in RA? ITIS vs Mediterranean Diet
FEATURING
Antoni Chan,
Marta Sala-Climent
- 131 views
- November 28, 2023
- 1
RheumNow
ACR Convergence 2023 Highlights: Unravelling the Mechanism of Clots with JAK Inhibitors
FEATURING
Yuzaiful Yusof,
Dennis Mcgonagle
- 162 views
- November 24, 2023
- 1
RheumNow
ACR Convergence 2023 Highlights: Abstract Recap Panel - Wednesday
- 109 views
- November 28, 2023
RheumNow
ACR Convergence 2023 Highlights: Rheumatoid Arthritis Topic Panel
- 368 views
- November 24, 2023
- 3